ClinicalTrials.gg
RecruitingNCT06933680Updated Apr 18, 2025

Sphenopalatine Ganglion Block in Bimaxillary Orthognathic Surgery

An interventional study of Sphenopalatine Ganglion Block and Sham Block in Bimaxillar Surgery and Sphenopalatine Ganglion Block, sponsored by Bezmialem Vakif University. Recruiting at 1 site in Turkey. Open to participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2025-04-18.

Sponsored by Bezmialem Vakif University · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Primary completion was expected by May 2025, 1 year 6 months ago, but the record still lists the study as recruiting.
  • Registered 9 months after the study started (first participant enrolled Jun 2024, registered Mar 2025).
  • Started Jun 2024; still recruiting 2 years 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 10 studies in Pain by Bezmialem Vakif University — 3 open to participants now, 3 under way, none of them phase 3. Pain · Bezmialem Vakif University.

Started
2024
the only one that year
No phase
9 of 10
3 open now
Registered
6th of 10
by date

Among the 10 studies in Pain by Bezmialem Vakif University, this one is the only one that started in 2024, is one of 9 with no phase, and was the 6th registered.

Pain

10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.

Browse Pain studies →

Open to participants now

3 of the 10 studies in Pain by Bezmialem Vakif University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.

This study: 18 Years to 45 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Pain by Bezmialem Vakif University, or all of them as a file.
02

Study summary

The goal of this clinical trial is to evaluate whether sphenopalatine ganglion (SPG) block helps with intraoperative pain control, reduces postoperative edema, and decreases pain in adults aged 18 to 45 undergoing bimaxillary orthognathic surgery.

The main questions it aims to answer are:

  • Does SPG block help decrease postoperative swelling and pain compared to a sham block?
  • Does it improve pain control during surgery and reduce opioid use? Researchers will compare patients receiving SPG block to those receiving a sham block to determine if this technique provides better pain relief and reduces postoperative complications.

Participants will:

  • Be 18 to 45 years old and undergo bimaxillary orthognathic surgery.
  • Be randomly assigned to receive either a SPG block or a sham block before surgery.
  • Be monitored for 1 month after surgery to assess pain levels, swelling, opioid use, and possible complications.
Read the detailed description

Orthognathic surgery is a procedure used to correct jaw bone problems that are present from birth or develop over time. During this surgery, multiple cuts, tissue separation, and bone reshaping (osteotomy) are done on the upper and lower jaw. After the surgery, the body responds with an inflammatory reaction, causing edema and pain. As the tissues heal, the edema and pain gradually decrease.

Edema is a common result of orthognathic surgery and can affect recovery time, return to normal activities, and hospital stay. Research shows that reducing edema can improve a patient's quality of life. Excessive edema can also cause pain and discomfort. To manage this, treatments such as steroids, laser therapy, lymphatic drainage massage, and cold applications are used.

The SPG is a nerve center that contains both sensory and autonomic nerve fibers. It connects to the trigeminal nerve, facial nerve, internal carotid plexus, and superior cervical ganglion. The SPG plays a role in widening brain blood vessels, providing sensation to the soft palate, tonsils, upper lip, and mouth floor, and controlling tear gland secretions.

In our study, it is anticipated that SPG block may help prevent intraoperative abnormal hemodynamic changes (by facilitating the control of heart rate and mean arterial pressure), reduce bleeding, decrease anesthetic drug consumption, lower the incidence of postoperative nausea and vomiting, and improve postoperative pain control and edema reduction. As a result, the postoperative comfort of patients undergoing orthognathic surgery can be enhanced with a cost-effective and easily applicable method, potentially reducing the risk of chronic pain in the long term. Additionally, by minimizing surgery-related edema and jaw muscle spasms, patients may achieve an optimal quality of life more quickly. Due to the limited number of studies on this technique in oral and maxillofacial surgery, our study is expected to pave the way for future research in this area.

03

Conditions studied

  • Bimaxillar Surgery
  • Sphenopalatine Ganglion Block

Browse trials for

Keywords

  • sphenopalatine ganglion block
  • pain
  • bimaxillary orthognathic surgery
  • edema
  • swelling
04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with bimaxillary orthognathic surgery indication
  • Patients with American Society of Anesthesiologistsscores (ASA) I-II
  • Patients between the ages of 18-45

Exclusion criteria

Exclusion Criteria:

  • Patients with local anesthetic allergy
  • Patients undergoing genioplasty
  • Syndromes associated with secondary deformities in addition to jaw deformities
  • Patients with a history of jaw surgery
  • Patients with uncontrolled hypertension
  • Patients with a history of substance abuse
  • Patients with chronic pain lasting more than 3 months
  • Patients using analgesic and hypnotic agents for more than 2 weeks
  • Recent situations that may cause facial edema (tooth extraction, facial trauma, etc.)
  • Patients with psychiatric disorders
  • Patients with diabetes mellitus
  • Patients with bleeding disorders
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
50 participants (estimated)

Study arms

  • Active comparator
    SPG block group

    This group will receive a SPG block using 4 ml of 5% bupivacaine after entübastion.

    Procedure: Sphenopalatine Ganglion Block

  • Sham comparator
    control group

    This group will receive a sham block using the same method using 4 ml of physiological saline after intubation.

    Procedure: Sham Block

Interventions

  • ProcedureSphenopalatine Ganglion Block

    To perform an SPG block, the ultrasound linear probe is placed parallel to the zygomatic bone, facing anteriorly, to obtain an image that includes the ramus of the maxilla and mandible and the pterygoid process of the sphenoid bone. A 23-gauge, 50 mm needle is inserted just behind the posterior orbital rim and advanced in an antero-caudal direction over the zygomatic arch. When the needle reaches the pterygopalatine fossa at approximately 5 cm, aspiration is performed to check for blood. If no blood is seen, 4 mL of 0.5% bupivacaine is injected. The procedure is performed on both sides

    Also known as: Meckel ganglion block, pterygopalatine ganglion block

  • ProcedureSham Block

    To perform a Sham block, the ultrasound linear probe is placed parallel to the zygomatic bone, facing anteriorly, to obtain an image that includes the ramus of the maxilla and mandible and the pterygoid process of the sphenoid bone. A 23-gauge, 50 mm needle is inserted just behind the posterior orbital rim and advanced in an antero-caudal direction over the zygomatic arch. When the needle reaches the pterygopalatine fossa at approximately 5 cm, aspiration is performed to check for blood. If no blood is seen, 4 mL of %0,9 NaCl is injected. The procedure is performed on both sides.

06

What researchers measure

Primary outcomes

  1. Postoperative Edema

    Using the technique of Gabka and Matsumura, gonion, mentum, and tragus are marked with methylene blue before surgery. The distances between the marks are measured bilaterally in millimeters using a flexible ruler and recorded. The measurement points will include: * Tragus-labial commissure distance * Tragus-alar notch distance * Gonion-lateral canthus distance * Tragus-mentum distance Postoperatively, edema measurements are taken from the same points.

    Time frame: Measurements are taken preoperatively, at 24 hours postoperatively, on postoperative day 3, day 7 and at 1 month.

  2. Postoperative Pain

    The numeric rating scale(NRS) is used to evaluate postoperative pain. Patients are asked to rate their pain on the scale of 0 to 10, with 0 indicating no pain and 10 indicating unbearable pain. Nrs scores are recorded.

    Time frame: The patient's pain at rest and during movement is evaluated at 30 minutes, 6 hours, 12 hours, 24 hours and 48 hours following the end of the surgery.

Secondary outcomes

  1. Effect of the Block on Temperature

    Starting before the block, the forehead skin temperature will be recorded every 5 minutes for 1 hour. During this period, the block time and surgical draping time are noted.

    Time frame: Measurements are taken every 5 minutes for the first 1 hour after induction.

  2. Heart rate

    Heart rate is monitored and recorded perioperatively using noninvasive monitoring.

    Time frame: Measurements are taken every 15 minutes preoperatively and throughout the surgery

  3. Mean arterial pressure

    Mean arterial pressure is monitored and recorded perioperatively using noninvasive monitoring.

    Time frame: Measurements are taken every 15 minutes preoperatively and throughout the surgery

  4. Opioid and Anesthetic Agent Consumption

    The amount of sevoflurane required to maintain the bispectral index (BIS) value within the target range and the total remifentanil used are recorded at the end of each patient's surgery.

    Time frame: The agents used during surgery are recorded once at the end of anesthesia.

  5. Quality of the surgical field

    The surgeon assesses the quality of the surgical field using a predefined category scale, adapted from Fromme GA et al. at the end of the surgery. Fromme Scale : * Grade 1: Massive uncontrollable bleeding * Grade 2: Bleeding, heavy but controllable, that significantly interferes with dissection * Grade 3: Moderate bleeding that moderately compromises surgical dissection * Grade 4: Moderate bleeding, a nuisance but without interfering with aaccurate dissection * Grade 5: Bleeding, so mild it was not even a surgical nuisance * Grade 6: No bleeding, virtually bloodless field

    Time frame: That is recorded once at the end of surgery.

  6. Postoperative Analgesic Consumption

    As a secondary parameter for pain assessment, the amount of opioid analgesic (tramadol) used, the number of requests and the need for rescue analgesics are recorded through patient-controlled analgesia devices.

    Time frame: These assessments are recorded at 30 minutes, 6 hours, postoperative day 1, day 2 and day 3.

  7. Mouth Opening

    The distance between font teeth is measured and recorded with soft ruler.

    Time frame: Measurements are taken preoperatively, on postoperative day 1, day 3, and day 7.

  8. Nausea and Vomiting

    Nausea and vomiting are evaluated using a 4-point categorical scale 0 = No nausea 1. = Nausea only 2. = Nausea with retching 3. = Vomiting

    Time frame: These assessments are recorded at 30 minutes, 6 hours, postoperative day 1, day 2 and day 3.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Smith CR, Dickinson KJ, Carrazana G, Beyer A, Spana JC, Teixeira FJP, Zamajtuk K, Maciel CB, Busl KM. Ultrasound-Guided Suprazygomatic Nerve Blocks to the Pterygopalatine Fossa: A Safe Procedure. Pain Med. 2022 Aug 1;23(8):1366-1375. doi: 10.1093/pm/pnac007. PubMed 35043949 ↗
  • Sumphaongern T, Chantarangsu S. Effect of Dexmedetomidine on Blood Loss and Patient Outcomes in Orthognathic Surgery: A Randomised Clinical Trial. Int Dent J. 2025 Jan 28:S0020-6539(25)00015-2. doi: 10.1016/j.identj.2025.01.009. Online ahead of print. PubMed 39880716 ↗
  • Keyhan SO, Fallahi HR, Cheshmi B, Mokhtari S, Zandian D, Yousefi P. Use of piezoelectric surgery and Er:YAG laser:which one is more effective during impacted third molar surgery? Maxillofac Plast Reconstr Surg. 2019 Aug 6;41(1):29. doi: 10.1186/s40902-019-0212-6. eCollection 2019 Dec. PubMed 31448247 ↗
  • Sari N, Uysal E. Endoscopic Sphenopalatine Ganglion Block Efficacy in the Management of Periorbital Edema and Ecchymosis After Septorhinoplasty. J Craniofac Surg. 2021 May 1;32(3):983-987. doi: 10.1097/SCS.0000000000007189. PubMed 33055565 ↗
  • Robiony M, Demitri V, Costa F, Politi M, Cugini U. Truncal anaesthesia of the maxillary nerve for outpatient surgically assisted rapid maxillary expansion. Br J Oral Maxillofac Surg. 1998 Oct;36(5):389-91. doi: 10.1016/s0266-4356(98)90653-2. PubMed 9831062 ↗
  • Shah RJ, Dixon B, Padalia D. Sphenopalatine Ganglion Radiofrequency Thermocoagulation. 2023 Jul 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK536944/ PubMed 30725629 ↗
  • Dominguez Camacho A, Velasquez SA, Benjumea Marulanda NJ, Moreno M. Photobiomodulation as oedema adjuvant in post-orthognathic surgery patients: A randomized clinical trial. Int Orthod. 2020 Mar;18(1):69-78. doi: 10.1016/j.ortho.2019.09.004. Epub 2019 Oct 31. PubMed 31678060 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2024 (actual). Primary completion is estimated for May 2025, 10 months after the start.

Of 3,749 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's planned 10 months is close to that.

Counting every sponsor, half of 3,848 studies reached it within 10 months; a quarter within 4 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 27, 2025
First posted
Apr 18, 2025
StartActual
Jun 25, 2024
Primary completionEst.
May 1, 2025
CompletionEst.
May 15, 2025
Last update
Apr 18, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 18, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06933680
Responsible party
Büşra Ceylan (Resident Physician in Anesthesiology and Reanimation, Bezmialem Vakif University) — Principal investigator
First posted
Apr 18, 2025
Start date
Jun 25, 2024
Primary completion
May 1, 2025 (estimated)
Completion
May 15, 2025 (estimated)
Last update
Apr 18, 2025

Study contacts

Büşra Ceylan, Resident Doctor
Contact
bcalis@bezmialem.edu.tr
+905058945208
Harun Uysal, Associate Professor
Contact
drharunuysal@hotmail.com
+905063433494
Büşra Ceylan, Resident Doctor
principal investigator · Bezmialem Vakıf Üniversitesi
Harun Uysal, Associate Professor
study director · Bezmialem Vakıf Üniversitesi
Ayda Türköz, Professor Doctor
study director · Medipol Acıbadem District Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion